Stock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription

Stock Track

May 05

STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.

The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.

Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1121276220"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1121276220\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1121276220?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 09:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121276220","market":"sg","top_or_hot":-1,"title":"Stock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription","media":"Stock Track","content":"<p>STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.</p><p>The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.</p><p>Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | STAR SPORTS MED Soars 181.22% on IPO Debut Following Record 7,823 Times Oversubscription\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-05 09:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.</p><p>The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.</p><p>Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01609","symbol_name":"天星医疗","start_time":0,"source_url":"","article_id":"1121276220","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121276220","pubTimestamp":1777944969,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.The explosive price...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01609":"天星医疗"},"translate_title":"股票赛道|Star Sports MED IPO首秀飙升181.22%超额认购创纪录7823倍","themeId":"a7761229170f08698a0131c7dfef2f92","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01609":1},"content_text":"STAR SPORTS MED (01609) surged 181.22% intraday on its debut trading session, reflecting overwhelming investor demand for the medical device company's initial public offering.The explosive price movement follows an extraordinarily oversubscribed IPO, with the Hong Kong public offering receiving 7,823.13 times more applications than available shares. The international placement was also oversubscribed at 10.41 times, indicating strong institutional interest. The company raised approximately HK$758.4 million in net proceeds from the global offering.Star Sports Medicine is China's largest domestic sports medicine implant and instrument provider, holding approximately 6.5% market share in the segment. The company's strong market position and growth prospects in China's healthcare sector contributed to the exceptional investor enthusiasm surrounding its market debut.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}